DEF: ZimVie Inc. Announces Key Governance Changes, Focuses on Dental Business

ZimVie Inc. completes the sale of its Spine business, refocuses on dental, and announces leadership changes including Vafa Jamali assuming the role of Chair and Vinit Asar becoming Lead Independent Director.

Summary

• ZimVie Inc. is holding its annual shareholder meeting on May 7, 2025, to elect a Class III director, ratify the appointment of PricewaterhouseCoopers LLP (PwC) as its independent registered public accounting firm for 2025, and approve executive compensation.
• In 2024, ZimVie completed the sale of its Spine business to become a pure-play Dental company for $377 million.
• The Board of Directors recommends shareholders vote FOR the election of Vafa Jamali as Class III director, FOR the ratification of PwC, and FOR the advisory vote on executive compensation.
• Effective May 7, 2025, Vafa Jamali will assume the role of Chair, and Vinit Asar will become Lead Independent Director.
• The company's executive compensation program is designed to align executives' financial interests with those of shareholders, with a significant portion of compensation tied to performance.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting the company's transformation into a pure-play dental business and its focus on growth and innovation. However, it also acknowledges the risks and uncertainties associated with forward-looking statements.

Positives

• The company has a diverse Board with an effective mix of skills, experiences, and perspectives.
• The company has an effective annual Board and Board committee evaluation process.
• The company has a majority voting and director resignation policy in uncontested director elections.
• The company has 100% independent directors, except for the CEO.
• The company has independent Board committees.
• The company has a robust Code of Business Conduct and Ethics applicable to directors, officers, and other team members.
• The company has rigorous stock ownership guidelines for directors and executives.
• The company has a single class voting structure (one share, one vote).
• The company has no supermajority voting requirements.
• The company has no poison pill.

Risks

• The document mentions a cautionary note regarding forward-looking statements, which are subject to significant risks, uncertainties, and changes in circumstances.
• The document references the Risk Factors section in the 2024 Annual Report on Form 10-K for a detailed discussion of risks, uncertainties, and changes in circumstances that could cause actual results and events to differ materially from forward-looking statements.

Future Outlook

The company is focused on building on its progress and pursuing new opportunities for growth in the dental industry.

Management Comments

• Vafa Jamali, President and CEO, stated that 2024 marked a significant transformation for ZimVie by completing the sale of the Spine business to become a pure-play Dental company.
• Vafa Jamali, President and CEO, stated that the company refocused its organization, delivered new innovations, and refined its operations to improve its financial health and deliver value for the dental industry and the communities it serves.

Industry Context

The document positions ZimVie as an innovative tooth replacement company focused on creating great customer experiences through practice workflow improvements and outstanding clinical outcomes in the dental market.

Management Changes

Stakeholder Impact

• Shareholders: The company aims to deliver value through its focus on the dental business and its commitment to effective corporate governance.
• Employees: The company emphasizes attracting, retaining, and motivating a highly qualified and effective senior leadership team.
• Customers: The company is focused on creating great customer experiences through practice workflow improvements and outstanding clinical outcomes.
• Dental Industry: The company aims to advance clinical technology foundational to restoring daily life.

Next Steps

• Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its annual meeting on May 7, 2025.
• The company will continue to focus on its dental business and pursue new opportunities for growth.

Key Dates

Keywords

ZimVie, Dental, Proxy Statement, Shareholders, Board of Directors, Executive Compensation, Corporate Governance, PricewaterhouseCoopers, Director Election, Annual Meeting